Ciprofloxacin Hydrochloride Encapsulated into PLGA Nanoparticles for Drug Delivery Application: Fractional Factorial Design - Open Access Library Journal

OALibJ > Vol.5 No.2, February 2018

Volume 5, Issue 2 (February 2018)

ISSN Print: 2333-9705 ISSN Online: 2333-9721

Google-based Impact Factor: 0.73 Citations

Ciprofloxacin Hydrochloride Encapsulated into PLGA Nanoparticles for Drug Delivery Application: Fractional Factorial Design ()

HTML XML

Download as PDF (Size: 3392KB) PP. 1-14

DOI: 10.4236/oalib.1104294 388 Downloads 871 Views Citations

Author(s)

Tajudeen Adebileje^1,2*, Sikiru Adebileje³, P. O. Aye²

Affiliation(s)

¹Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences-International Campus (TUMS-IC), Tehran, Iran.
²Department of Mathematical Sciences, Adekunle Ajasin University, Akungba-Akoko, Ondo State, Nigeria.
³Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences-International Campus (TUMS-IC), Tehran, Iran.

ABSTRACT

Over several decades, poly (lactic-co-glycolic acid) (PLGA) have been widely used as Micro-and Nano-carriers of therapeutic agents for drug delivery applications. However, encapsulation process of therapeutic agents into PLGA Nanoparticles (NPs) necessitates a defined step to understand the effects and interactions of parameters involved in production process. In pharmaceutics formulations, compared to one factor at a time (OFAT) approach, statistical design of experiments (DOE) supersedes OFAT approach due to limited number of experiments required to investigate effects and interactions of a process parameters. The major objectives of the present study were to: 1) prepare and understand the effect of selected formulation parameters on particles size and drug recovery of PLGA NPs encapsulating Ciprofloxacin Hydrochloride (Cip-HCl) using a fractional factorial design (FFD) as a DOE approach; 2) understand the in-vitro release of Cip-HCl from PLGA NPs. Cip-HCl loaded PLGA were prepared by W₁/O/W₂ double emulsion solvent evaporation (DESE) method using poly-vinyl alcohol as a stabilizer. The Sizes of NPs were within 202 nm to 530 nm and percentage Cip-HCl recovered from dried NPs were within 1.7% w/w to 15.7% w/w. Increasing concentrations of PLGA and Cip-HCl was observed to increase NPs size. Increasing PVA concentration was observed to either reduce or increase NPs size. Increasing PLGA concentration was observed to increase the amount of Cip-HCl recovered. Within 1-24 hours, optimized formulations shows a controlled release of Cip-HCl from PLGA NPs.

KEYWORDS

Ciprofloxacin Hydrochloride, PLGA Nanoparticles, Drug Recovery, Double Emulsion Solvent Evaporation, Fractional Factorial Design

Share and Cite:

Adebileje, T. , Adebileje, S. and Aye, P. (2018) Ciprofloxacin Hydrochloride Encapsulated into PLGA Nanoparticles for Drug Delivery Application: Fractional Factorial Design. Open Access Library Journal, 5, 1-14. doi: 10.4236/oalib.1104294.

Cited by

[1]	Experimental Study on Kinetics and Mechanism of Ciprofloxacin Degradation in Aqueous Phase Using Ag-TiO2/rGO/Halloysite Photocatalyst
	Catalysts, 2023

[2]	QbD-Steered Systematic Development of Drug Delivery Nanoconstructs: Vital Precepts, Retrospect and Prospects
	… Research: Drug Design …, 2022

[3]	Formulation of paracetamol−loaded poly(ε−caprolactone) nanoparticles by anti-solvent displacement method using glass capillary microfluidics: Statistical …
	AIP Conference …, 2022

[4]	Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A …
	Life Sciences, 2022

[5]	Quality-by-design in pharmaceutical development: From current perspectives to practical applications
	2021

[6]	Systematic Development of Drug Nanocargos Using Formulation by Design (FbD): An Updated Overview
	2020

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies